Where next?
The main players in the Chinese GenAI space can be divided into four groups:
- Government-supported research centers and labs
- Tech giants, including Alibaba, Baidu, Tencent, 360, ByteDance and Huawei
- Small-to-medium tech companies, which are unfamiliar names in the West
- Startups, including a few unicorns (with valuations over $1bn)
In the startup space, we are watching Moonshot AI, Minimax AI, ZhiPu AI, Baichuan AI, 01.AI, and Modelbest. These six startups have benefitted from venture capital inflows in the past few years, with deal sizes over U.S. $200m. The privately held Moonshot AI is now said to be worth over $3bn.
We see a lot of movement from China’s top technology companies and startups in both open-source and closed-source large models. Although this is an area where China is playing catch-up, it is of strategic importance to spur future growth.
In 2023, the total private investment in the generative AI field in China was about $650 million, compared with $22.46bn in the US, according to the Stanford 2024 AI Index Report. But as China’s central government is prioritizing GenAI solutions to help boost its economy and efficiency amid a shrinking workforce, the West should keep watch. With the central government’s support, local governments are setting ambitious objectives at a provincial or city level. For example, Nanjing city set a 2024-2026 policy goal:
- (a) To introduce and cultivate one foundational, large-scale model at the domestic and international advanced level by 2026,
- (b) To create more than 20 industry-specific large-scale models,
- (c) To develop 30 benchmark application scenarios each year, and
- (d) To achieve a core industry scale of 60 billion yuan in artificial intelligence.
The larger picture is clear: Chinese GenAI is worth following.